Breast and Ovarian Cancers' Incidence Trends Among Iraqi Women During 2012-2022 and Their Relationship to Fertility Patterns
- PMID: 40657466
- PMCID: PMC12255333
- DOI: 10.18295/2075-0528.2863
Breast and Ovarian Cancers' Incidence Trends Among Iraqi Women During 2012-2022 and Their Relationship to Fertility Patterns
Abstract
Objectives: This study aimed to estimate the incidence trends of female breast cancer (BC) and ovarian cancer (OC) among women in Iraq and their relation to fertility patterns.
Methods: This retrospective study utilised the Iraqi Cancer Registry annual reports for the years 2012-2022 and the World Bank data for Iraqi crude birth rate and total fertility data for the years 1992-2002. Simple linear regression analysis examined the relationship between these variables and incidence rates of BC and OC.
Results: A total of 63,446 women were newly diagnosed with BC from 2012-2022. The overall age standardised incidence rate (ASIR) of BC was 46.68/100,000 females. It increased significantly from 36.61/100,000 in 2012 to 61.89/100,000 in 2022 with an average annual percentage change (AAPC) of 4.83% (95% confidence interval [CI]: 2.69-7.08; P < 0.001). The overall ASIR rate of OC was 6.22/100,000 women. It increased significantly from 4.35/100,000 in 2012 to 6.90/100,000 in 2022 with an AAPC of 4.58% (95% CI: 2.40-6.88; P < 0.001). The ASIR of BC was negatively and significantly associated with crude birth rate (CBR) and total fertility (TFR) rate (R2 = 0.727; P = 0.001 and R2 = 0.728; P = 0.001, respectively). The ASIR of OC was negatively and significantly associated with CBR and TFR (R2 = 0.699; P = 0.001 and R2 = 0.696; P = 0.001, respectively).
Conclusions: Iraqi women are experiencing a rising incidence of breast and ovarian cancers over time. Lower fertility rates may partly play a role in this trend. Research and initiatives are necessary to identify and control the factors that are increasing this risk.
Keywords: Breast Cancer; Fertility; Incidence; Iraq; Ovarian Cancer.
© The Author(s) 2025.
Conflict of interest statement
The author declares no conflict of interest.
Figures




Similar articles
-
Antioxidants for female subfertility.Cochrane Database Syst Rev. 2017 Jul 28;7(7):CD007807. doi: 10.1002/14651858.CD007807.pub3. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Aug 27;8:CD007807. doi: 10.1002/14651858.CD007807.pub4. PMID: 28752910 Free PMC article. Updated.
-
Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.Cochrane Database Syst Rev. 2018 Aug 24;8(8):CD012464. doi: 10.1002/14651858.CD012464.pub2. Cochrane Database Syst Rev. 2018. PMID: 30141832 Free PMC article.
-
Antioxidants for female subfertility.Cochrane Database Syst Rev. 2013 Aug 5;(8):CD007807. doi: 10.1002/14651858.CD007807.pub2. Cochrane Database Syst Rev. 2013. Update in: Cochrane Database Syst Rev. 2017 Jul 28;7:CD007807. doi: 10.1002/14651858.CD007807.pub3. PMID: 23913583 Updated.
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280. Health Technol Assess. 2001. PMID: 11701100
-
Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility.Cochrane Database Syst Rev. 2013 Aug 13;2013(8):CD008215. doi: 10.1002/14651858.CD008215.pub2. Cochrane Database Syst Rev. 2013. Update in: Cochrane Database Syst Rev. 2019 Jun 18;6:CD008215. doi: 10.1002/14651858.CD008215.pub3. PMID: 23943232 Free PMC article. Updated.
References
-
- Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2024; 74:229–63. https://doi.org/10.3322/caac.21834. 10.3322/caac.21834 - DOI - DOI - PubMed
-
- Zahedi R, Molavi Vardanjani H, Baneshi MR, Haghdoost AA, Malekpour Afshar R, Ershad Sarabi R, et al. Incidence trend of breast cancer in women of eastern Mediterranean region countries from 1998 to 2019: A systematic review and meta-analysis. BMC Womens Health 2020; 20:53. https://doi.org/10.1186/s12905-020-00903-z. 10.1186/s12905-020-00903-z - DOI - DOI - PMC - PubMed
-
- Al-Hashimi MMY. Trends in breast cancer incidence in Iraq during the period 2000–2019. Asian Pac J Cancer Prev 2021; 22:3889–96. https://doi.org/10.31557/APJCP.2021.22.12.3889. 10.31557/APJCP.2021.22.12.3889 - DOI - DOI - PMC - PubMed
-
- Hossain MS, Ferdous S, Karim-Kos HE. Breast cancer in South Asia: A Bangladeshi perspective. Cancer Epidemiol 2014; 38:465–70. https://doi.org/10.1016/j.canep.2014.08.004. 10.1016/j.canep.2014.08.004 - DOI - DOI - PubMed
-
- Hussain AM, Lafta RK. Cancer trends in Iraq 2000–2016. Oman Med J 2021; 36:e219. https://doi.org/10.5001/omj.2021.18. 10.5001/omj.2021.18 - DOI - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous